Arena Pharmaceuticals, Inc. Debt to Equity Ratio 2010-2021 | ARNA
Current and historical debt to equity ratio values for Arena Pharmaceuticals, Inc. (ARNA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Arena Pharmaceuticals, Inc. debt/equity for the three months ending December 31, 2021 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2021-12-31 |
$0.11B |
$0.67B |
0.17 |
2021-09-30 |
$0.10B |
$0.80B |
0.13 |
2021-06-30 |
$0.11B |
$0.97B |
0.12 |
2021-03-31 |
$0.10B |
$1.09B |
0.09 |
2020-12-31 |
$0.11B |
$1.08B |
0.10 |
2020-09-30 |
$0.11B |
$1.17B |
0.09 |
2020-06-30 |
$0.10B |
$1.24B |
0.08 |
2020-03-31 |
$0.10B |
$0.99B |
0.10 |
2019-12-31 |
$0.10B |
$1.07B |
0.10 |
2019-09-30 |
$0.10B |
$1.15B |
0.08 |
2019-06-30 |
$0.08B |
$1.20B |
0.07 |
2019-03-31 |
$0.09B |
$1.24B |
0.07 |
2018-12-31 |
$0.08B |
$0.61B |
0.13 |
2018-09-30 |
$0.08B |
$0.53B |
0.15 |
2018-06-30 |
$0.08B |
$0.56B |
0.14 |
2018-03-31 |
$0.10B |
$0.58B |
0.17 |
2017-12-31 |
$0.13B |
$0.21B |
0.64 |
2017-09-30 |
$0.13B |
$0.22B |
0.60 |
2017-06-30 |
$0.11B |
$0.08B |
1.30 |
2017-03-31 |
$0.11B |
$0.03B |
4.24 |
2016-12-31 |
$0.13B |
$0.04B |
3.18 |
2016-09-30 |
$0.21B |
$0.00B |
50.57 |
2016-06-30 |
$0.20B |
$0.01B |
15.07 |
2016-03-31 |
$0.20B |
$0.04B |
5.43 |
2015-12-31 |
$0.20B |
$0.05B |
3.80 |
2015-09-30 |
$0.20B |
$0.08B |
2.48 |
2015-06-30 |
$0.22B |
$0.11B |
2.07 |
2015-03-31 |
$0.23B |
$0.13B |
1.81 |
2014-12-31 |
$0.23B |
$0.05B |
4.84 |
2014-09-30 |
$0.22B |
$0.08B |
2.89 |
2014-06-30 |
$0.23B |
$0.10B |
2.25 |
2014-03-31 |
$0.24B |
$0.13B |
1.92 |
2013-12-31 |
$0.25B |
$0.09B |
2.70 |
2013-09-30 |
$0.18B |
$0.11B |
1.63 |
2013-06-30 |
$0.15B |
$0.13B |
1.23 |
2013-03-31 |
$0.16B |
$0.08B |
1.94 |
2012-12-31 |
$0.16B |
$0.10B |
1.65 |
2012-09-30 |
$0.15B |
$0.12B |
1.25 |
2012-06-30 |
$0.15B |
$0.11B |
1.40 |
2012-03-31 |
$0.14B |
$0.05B |
3.19 |
2011-12-31 |
$0.15B |
$0.01B |
13.88 |
2011-09-30 |
$0.15B |
$0.04B |
4.27 |
2011-06-30 |
$0.15B |
$0.06B |
2.49 |
2011-03-31 |
$0.16B |
$0.08B |
1.99 |
2010-12-31 |
$0.19B |
$0.08B |
2.33 |
2010-09-30 |
$0.19B |
$0.11B |
1.77 |
2010-06-30 |
$0.16B |
$0.08B |
2.02 |
2010-03-31 |
$0.16B |
$0.07B |
2.31 |
2009-12-31 |
$0.16B |
$0.08B |
2.17 |
2009-09-30 |
$0.17B |
$0.10B |
1.61 |
2009-06-30 |
$0.12B |
$0.05B |
2.64 |
2009-03-31 |
$0.13B |
$0.07B |
2.01 |